Poole KE - Search Results

1

Sclerostin and the regulation of bone formation: Effects in hip osteoarthritis and femoral neck fracture.

Power J, Poole KE, van Bezooijen R, Doube M, Caballero-Alías AM, Lowik C, Papapoulos S, Reeve J, Loveridge N. Power J, et al. Among authors: poole ke. J Bone Miner Res. 2010 Aug;25(8):1867-76. doi: 10.1002/jbmr.70. J Bone Miner Res. 2010. PMID: 20200987 Free article.

2

Falls, fractures, and osteoporosis after stroke: time to think about protection?

Poole KE, Reeve J, Warburton EA. Poole KE, et al. Stroke. 2002 May;33(5):1432-6. doi: 10.1161/01.str.0000014510.48897.7d. Stroke. 2002. PMID: 11988628 Review.

3

Rapid long-term bone loss following stroke in a man with osteoporosis and atherosclerosis.

Poole KE, Warburton EA, Reeve J. Poole KE, et al. Osteoporos Int. 2005 Mar;16(3):302-5. doi: 10.1007/s00198-004-1682-6. Epub 2004 Jun 10. Osteoporos Int. 2005. PMID: 15197547

4

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.

Poole KE, van Bezooijen RL, Loveridge N, Hamersma H, Papapoulos SE, Löwik CW, Reeve J. Poole KE, et al. FASEB J. 2005 Nov;19(13):1842-4. doi: 10.1096/fj.05-4221fje. Epub 2005 Aug 25. FASEB J. 2005. PMID: 16123173

5

Parathyroid hormone - a bone anabolic and catabolic agent.

Poole KE, Reeve J. Poole KE, et al. Curr Opin Pharmacol. 2005 Dec;5(6):612-7. doi: 10.1016/j.coph.2005.07.004. Epub 2005 Sep 21. Curr Opin Pharmacol. 2005. PMID: 16181808 Review.

6

Risedronate therapy for prevention of hip fracture after stroke in elderly women.

Poole KE, Warburton EA, Reeve J. Poole KE, et al. Neurology. 2005 Nov 8;65(9):1513-4; author reply 1513-4. doi: 10.1212/wnl.65.9.1513. Neurology. 2005. PMID: 16275859 No abstract available.

7

Reduced vitamin D in acute stroke.

Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C, Reeve J, Warburton EA. Poole KE, et al. Stroke. 2006 Jan;37(1):243-5. doi: 10.1161/01.STR.0000195184.24297.c1. Epub 2005 Dec 1. Stroke. 2006. PMID: 16322500

8

A single infusion of zoledronate prevents bone loss after stroke.

Poole KE, Loveridge N, Rose CM, Warburton EA, Reeve J. Poole KE, et al. Stroke. 2007 May;38(5):1519-25. doi: 10.1161/STROKEAHA.106.474262. Epub 2007 Mar 29. Stroke. 2007. PMID: 17395868 Clinical Trial.

9

Yearly zoledronic acid in postmenopausal osteoporosis.

Poole KE, Kaptoge S, Reeve J. Poole KE, et al. N Engl J Med. 2007 Aug 16;357(7):711-2; author reply 714-5. N Engl J Med. 2007. PMID: 17703530 No abstract available.

10

Bone structure and remodelling in stroke patients: early effects of zoledronate.

Poole KE, Vedi S, Debiram I, Rose C, Power J, Loveridge N, Warburton EA, Reeve J, Compston J. Poole KE, et al. Bone. 2009 Apr;44(4):629-33. doi: 10.1016/j.bone.2008.11.017. Epub 2008 Dec 11. Bone. 2009. PMID: 19121416 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters